Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.
Current Value
$10.151 Year Return
Current Value
$10.151 Year Return
Market Cap
$859.91M
P/E Ratio
-6.26
1Y Stock Return
53.94%
1Y Revenue Growth
-14.78%
Dividend Yield
0.00%
Price to Book
7.8
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SCS | 25.29% | $1.49B | +8.36% | 3.06% |
PCT | 24.14% | $1.93B | +208.73% | 0.00% |
TTC | 22.53% | $8.29B | -3.76% | 1.78% |
BECN | 21.30% | $6.76B | +34.86% | 0.00% |
RUSHA | 21.26% | $4.66B | +53.97% | 1.18% |
MOD | 20.38% | $7.14B | +163.53% | 0.00% |
GMS | 20.24% | $3.90B | +50.71% | 0.00% |
KRUS | 20.18% | $1.03B | +38.71% | 0.00% |
BVN | 19.99% | $3.16B | +37.49% | 0.00% |
XMTR | 19.83% | $1.48B | +50.13% | 0.00% |
UEC | 19.41% | $3.54B | +34.59% | 0.00% |
OSCR | 19.33% | $4.45B | +121.80% | 0.00% |
ATI | 19.29% | $8.31B | +32.37% | 0.00% |
HLIT | 18.93% | $1.42B | +12.53% | 0.00% |
KYMR | 18.87% | $2.77B | +125.95% | 0.00% |
COHR | 18.85% | $16.12B | +196.84% | 0.00% |
LAD | 18.44% | $9.87B | +38.08% | 0.56% |
OSW | 18.41% | $1.95B | +65.90% | 0.21% |
ROAD | 18.40% | $4.91B | +118.93% | 0.00% |
AMWD | 18.36% | $1.46B | +29.41% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OZK | -<0.01% | $5.44B | +17.21% | 3.30% |
KRNY | -0.01% | $526.32M | +4.49% | 5.40% |
OMF | 0.02% | $6.51B | +43.89% | 7.52% |
AVO | 0.02% | $930.35M | +49.60% | 0.00% |
ATOM | -0.02% | $160.01M | -20.00% | 0.00% |
ASH | -0.02% | $3.73B | -1.96% | 2.08% |
BEST | -0.03% | $31.65M | +3.88% | 0.00% |
LTC | 0.03% | $1.75B | +19.49% | 5.93% |
ZYXI | -0.03% | $249.03M | -12.53% | 0.00% |
NGS | 0.03% | $320.33M | +71.20% | 0.00% |
ZI | -0.04% | $3.40B | -28.47% | 0.00% |
NICE | -0.04% | $10.86B | -11.14% | 0.00% |
RBRK | 0.05% | $8.03B | +38.16% | 0.00% |
SAM | -0.05% | $3.58B | -7.64% | 0.00% |
SFIX | -0.05% | $480.74M | +11.14% | 0.00% |
VLTO | -0.05% | $25.72B | +43.80% | 0.34% |
CNOB | -0.06% | $1.03B | +41.32% | 2.65% |
VCEL | 0.07% | $2.76B | +55.60% | 0.00% |
EPC | 0.07% | $1.69B | +0.38% | 1.74% |
VUZI | -0.07% | $78.77M | -51.69% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UTHR | -23.65% | $16.10B | +56.54% | 0.00% |
GIS | -22.76% | $34.85B | -2.91% | 3.78% |
ARGX | -21.31% | $34.68B | +17.58% | 0.00% |
AON | -20.99% | $82.00B | +16.33% | 0.70% |
CAG | -19.81% | $12.64B | -6.10% | 5.26% |
RNR | -19.75% | $13.74B | +23.09% | 0.58% |
XPER | -18.55% | $378.82M | -19.06% | 0.00% |
CPB | -17.94% | $12.96B | +7.08% | 3.40% |
AFL | -17.82% | $61.74B | +35.69% | 1.35% |
PEP | -17.27% | $215.02B | -6.60% | 3.35% |
KMPR | -17.11% | $4.52B | +69.87% | 1.75% |
SO | -16.69% | $96.74B | +26.76% | 3.24% |
PNW | -16.49% | $10.34B | +26.67% | 3.90% |
CB | -16.30% | $114.43B | +26.00% | 1.24% |
DXC | -15.92% | $3.55B | -14.64% | 0.00% |
LGF.A | -15.62% | $1.83B | -20.52% | 0.00% |
PG | -15.50% | $402.15B | +14.14% | 2.33% |
HIG | -15.48% | $33.87B | +51.09% | 1.60% |
ED | -15.20% | $33.59B | +7.16% | 3.43% |
LGF.B | -15.18% | $1.63B | -25.36% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QQA | 22.26% | $135.01M | 0% |
FMF | 18.71% | $244.61M | 0.95% |
IMOM | 18.38% | $80.57M | 0.39% |
URNM | 17.61% | $1.61B | 0.75% |
HYEM | 16.67% | $408.28M | 0.4% |
HDRO | 16.26% | $164.26M | 0.3% |
URNJ | 15.47% | $283.55M | 0.8% |
BUXX | 15.45% | $162.67M | 0.25% |
CSHI | 15.20% | $482.85M | 0.38% |
XBI | 15.18% | $6.58B | 0.35% |
AGGY | 14.93% | $926.64M | 0.12% |
BKCH | 14.91% | $204.99M | 0.5% |
IBHD | 14.86% | $327.80M | 0.35% |
CEMB | 14.85% | $435.28M | 0.5% |
EMBD | 14.82% | $195.52M | 0.39% |
XPH | 14.61% | $157.87M | 0.35% |
PTH | 14.53% | $143.31M | 0.6% |
VWOB | 14.39% | $5.40B | 0.2% |
PFF | 14.24% | $15.20B | 0.46% |
FLMI | 14.24% | $356.19M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GXC | -0.01% | $433.32M | 0.59% |
USDU | 0.04% | $201.97M | 0.5% |
JPEM | 0.05% | $318.90M | 0.44% |
MCHI | 0.08% | $5.57B | 0.59% |
OIH | 0.09% | $1.69B | 0.35% |
DIVO | 0.10% | $3.74B | 0.56% |
FNCL | 0.11% | $2.03B | 0.084% |
FTSM | 0.12% | $6.08B | 0.45% |
DGRO | 0.15% | $30.46B | 0.08% |
FVD | 0.18% | $9.70B | 0.6% |
AMLP | 0.19% | $9.45B | 0.85% |
FXO | -0.20% | $1.02B | 0.62% |
TPHD | 0.22% | $242.19M | 0.52% |
IXG | -0.22% | $441.53M | 0.42% |
VFH | -0.25% | $11.71B | 0.1% |
PXE | -0.26% | $117.58M | 0.63% |
IBTE | 0.29% | $1.70B | 0.07% |
PXH | 0.31% | $1.20B | 0.49% |
PEY | -0.32% | $1.24B | 0.53% |
DLN | -0.32% | $4.41B | 0.28% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SOYB | -16.79% | $27.32M | 0.22% |
FTXG | -15.85% | $30.81M | 0.6% |
IYK | -15.74% | $1.30B | 0.4% |
TBLL | -15.71% | $1.92B | 0.08% |
CORN | -15.61% | $61.12M | 0.2% |
IAK | -15.06% | $760.79M | 0.39% |
BTAL | -14.99% | $388.04M | 1.43% |
LVHD | -13.83% | $560.70M | 0.27% |
FLRN | -13.53% | $2.33B | 0.15% |
HDV | -13.45% | $11.19B | 0.08% |
DBA | -13.35% | $755.88M | 0.93% |
XLP | -12.87% | $16.03B | 0.09% |
KIE | -12.72% | $956.77M | 0.35% |
SPLV | -11.97% | $8.93B | 0.25% |
IDU | -11.78% | $1.43B | 0.39% |
FSTA | -11.71% | $1.20B | 0.084% |
SPHD | -11.69% | $3.46B | 0.3% |
XLU | -11.49% | $16.89B | 0.09% |
VDC | -11.32% | $7.09B | 0.1% |
VPU | -10.94% | $6.66B | 0.1% |
Yahoo
As geopolitical tensions rise, the U.S. stock market has experienced early declines, with major indices such as the Dow Jones Industrial Average and S&P 500 slipping amid investor concerns. In this environment of uncertainty, stocks with substantial insider ownership can offer a unique perspective on potential growth opportunities, as insiders may have confidence in their company's long-term prospects despite short-term market fluctuations.
Yahoo
Liquidia ( NASDAQ:LQDA ) Third Quarter 2024 Results Key Financial Results Revenue: US$4.45m (up 21% from 3Q 2023). Net...
SeekingAlpha
Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stockâs valuation and upcoming launches make it a strong buy.
SeekingAlpha
United Therapeutics is a leader in PAH treatments, with Tyvaso being the primary revenue driver. Check out why I rate UTHR stock a buy for long-term investors.
SeekingAlpha
United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with promising treatments and cash reserves.
Yahoo
Liquidia Corp (LQDA) outlines promising clinical progress and strategic partnerships while navigating regulatory and financial hurdles.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.